Belgium· BE-AMP-SAM328325-00
Ceplene 0.5 mg/0.5 ml
A histamine dihydrochloride product containing histamine dihydrochloride, registered in Belgium by Noventia Pharma. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Histamine dihydrochloride is registered in 10 of 19 countries.
Countries holding a registration under ATC L03AX14 (histamine dihydrochloride), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Histamine dihydrochloride · ATC L03AX14
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Histamine Dihydrochloride
- Manufacturer
- Noventia Pharma
- Country
- Belgium (BE)
- ATC code
- L03AX14
- ATC class
- Histamine dihydrochloride
- Defined daily dose
- 0.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
42 interactions on record for histamine dihydrochloride.
Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Histamine dihydrochloride · interactions on record
42 records
- 42 moderate
Most severe, free to view
- DiphenhydraminA04AB05moderate
- CyproheptadinA15AA01moderate
- DiphenhydraminN01BX06moderate
- HydroxyzineN05BB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Histamine dihydrochloride in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCEPLENELaboratoires Delbert, Paříž
- SpainCEPLENE 0,5 mg/0,5 ml SOLUCION INYECTABLELaboratoires Delbert
- IcelandCepleneLaboratoires Delbert
- NorwayCepleneLaboratoires Delbert
- PolandCepleneLaboratoires Delbert
- SwedenCeplene 0,5 mg/0,5 ml Injektionsvätska, lösningLaboratoires Delbert
- United States2nd CHANCE MOBILITY Pain ReliefALPHA NUTRITION, LLC
- United KingdomCeplene 0.5mg/0.5ml solution for injection vialsMeda Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Alk Prick Positiv Kontrolle, Alyostal Prick, Allergenextrakte
- Bulgaria · Алиостал Прик, Алергенен Екстракт От Дървесни Полени, Алиостал Прик, Алергенен Екстракт От Животински Произход
- Czechia · Alyostal Prick, Soluprick Sq
- Germany · Alk-Prick Positiv-Kontrolle, Histamin-Kontrollösung Bencard Allergie
- Denmark · Alk Soluprick Positiv Kontrol
- Finland · Soluprick Positiivinen Kontrolli, Soluprick® Positiv Kontroll
- France · Alyostal Prick Controle Positif, Soluprick Controle Positif
- United Kingdom (Northern Ireland) · Soluprick Positive Control
- Ireland · Soluprick Positive Control
- Iceland · Ceplene, Soluprick Positiv Kontrol
- Liechtenstein · Ceplene
- Lithuania · Alyostal Prick Teigiama Kontrolė
- Luxembourg · Soluprick Contrôle Positif, Soluprick Positiv Kontrolle
- Netherlands · Prick Test Positieve Controle, Soluprick Controlevloeistoffen
- Norway · Ceplene, Soluprick Positiv Kontroll
- Poland · Alyostal, Kontrola Dodatnia Prick Test Hal Allergy
- Portugal · Histamina Hal Allergy
- Sweden · Soluprick Positiv Kontroll
- Slovenia · Alyostal Vbodni
- Slovakia · Alyostal Prick, Soluprick
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4c174501-06d2-4ea0-8d2d-63be915289b3 GET /v1/drugs/4c174501-06d2-4ea0-8d2d-63be915289b3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Ceplene 0.5 mg/0.5 ml",
"name_fr": "Ceplene 0.5 mg/0.5 ml",
"name_nl": "Ceplene 0.5 mg/0.5 ml",
"amp_code": "SAM328325-00",
"strengths": [
"0.5000"
],
"pack_count": 1,
"substances": [
"Histamine Dihydrochloride",
"Sodium Chloride",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Histamine Dihydrochloride",
"authorisation_numbers": [
"EU/1/08/477/001"
]
}See everything about histamine dihydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.